ExLibris header image
SFX Logo
Title: Suppression of MTHFD2 in MCF-7 Breast Cancer Cells Increases Glycolysis, Dependency on Exogenous Glycine, and Sensitivity to Folate Depletion
Source:

Journal of Proteome Research [1535-3893] Koufaris, Costas yr:2016


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Hitzel, J. "Integrative analysis of endothelial Bayesian Networks reveals MTHFD2 as a keydriver for selective amino acid metabolism in response to oxidized phospholipids." Acta physiologica 2017. 88-90. Link to Full Text for this item Link to SFX for this item
2. Aumailley, L. "Impact of vitamin C on the cardiometabolic and inflammatory profiles of mice lacking a functional Werner syndrome protein helicase." Experimental gerontology 72 (2015): 192-203. Link to SFX for this item
3. Juvekar, A. "Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion." Proceedings of the National Academy of Sciences of the United States of America 113.30 (2016): 4338-47. Link to Full Text for this item Link to SFX for this item
4. Gustafsson, R. "Crystal structure of the emerging cancer target MTHFD2 in complex with a substrate-based inhibitor." Cancer research 77.4 (2016): 937-5472. Link to SFX for this item
5. Bertino, Joseph R. "MTHFD2--a new twist?" Oncotarget 7.7 (2016): 7368-7369. Link to Full Text for this item Link to SFX for this item
6. Lien, Evan C. "Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer." Nature Cell Biology 18.5 (2016): 572-578. Link to SFX for this item
7. Scully, R. "Double strand break repair functions of histone H2AX." Mutation research 750.1-2 (2013): 5-14. Link to SFX for this item
8. Juvekar, A. "Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for a mouse model of BRCA1-related breast cancer." Cancer discovery 2.11 (2012): 1048-1063. Link to SFX for this item
9. Petersen, Lars F. "Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells." BJU international 109.5 (2012): 788-795. Link to Full Text for this item Link to SFX for this item
10. Ibrahim, Yasir H. "PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA proficient triple negative breast cancer to PARP inhibition." Cancer discovery 2.11 (2012): 1036-1047. Link to SFX for this item
11. "The First Structure of Human MTHFD2L and Its Implications for the Development of Isoform-Selective Inhibitors." ChemMedChem. 17.18. Link to SFX for this item
12. Park, S. "ERRĪ±-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer." Cell Reports 15.2 (2016): 323-335. Link to SFX for this item
13. Settleman, J. "mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells." Cancer cell 29.4 (2016): 548-562. Link to SFX for this item
14. Kerr, Emma M. "Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities." Nature 531.7592 (2016): 110-113. Link to Full Text for this item Link to SFX for this item
15. Gustafsson Sheppard, N. "The folate-coupled enzyme MTHFD2 is a nuclear protein and promotes cell proliferation." Scientific Reports 5 (2015): 15029-15029. Link to Full Text for this item Link to SFX for this item
16. Bayraktar, S. "Systemic therapy options in BRCA mutation-associated breast cancer." Breast cancer research and treatment 135.2 (2012): 355-366. Link to Full Text for this item Link to SFX for this item
17. Kuroda, S. "Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization." Acta medica Okayama 66.2 (2012): 83-92. Link to SFX for this item
18. Fostira, F. "Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study." Breast cancer research and treatment 134.1 (2012): 353-362. Link to Full Text for this item Link to SFX for this item
19. Gallinat, S. "Folic acid and creatine improve the firmness of human skin in vivo." Journal of cosmetic dermatology 10.1 (2011): 15-23. Link to Full Text for this item Link to SFX for this item
20. Shibata, A. "Factors determining DNA double-strand break repair pathway choice in G2 phase." EMBO journal 30.6 (2011): 1079-92. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced